A once hidden (and probably destined to be hidden again) document from the FDA justifying the safe usage of Hydroxychloroquine (HCQ) as an effective treatment against COVID-19 is exposed by the journalists at The National Pulse. What is more heinously shocking is the reason the FDA buried HCQ good news! After reading the FDA/HCQ exposé, I’m providing a list of source substantiating HCQ usage science to co-opt HCQ liars at the end of The National Post article.
Your generosity is always appreciated – various credit, check
& debit cards are accepted by my PayPal account:
Or support by getting in the Coffee from home business –
OR just buy some FEEL GOOD coffee, that includes immune boosting products.
EXCLUSIVE: Hidden FDA Doc Explains Why “Liar” Fauci Opposes Hydroxychloroquine, Top Doctors Explain
By Staff Writer
August 4, 2020
The National Pulse
A document no longer available from the U.S. Food and Drug Administration regarding “Emergency Use Authorization” of potential COVID-19 treatments appears to suggest that hydroxychloroquine satisfies the criteria for the classification, but would stand in the way of lucrative other drugs, and a vaccine.
The possible treatment, shunned by the mainstream media and Big Tech, has far-ranging champions from Yale epidemiologists to frontline doctors to President Trump. Despite this support, corroborated by scientific studies, the medical establishment under the auspices of Dr. Anthony Fauci have refused to grant hydroxychloroquine “Emergency Use Authorization” (EUA).
July 29th documents from a Food and Drug Administration (FDA) presentation reveal, however, that the “qualifying criteria” for extending EUA to the drug appear to have been met: it “may be effective” and that “no adequate, approved, and available alternative” exists.
The document makes clear that Emergency Use Authorization cannot be used for more than one drug or therapeutic, and the establishment is potentially therefore saving the EUA pre-emptively for vaccines and remdesivir – patently high-value Big Pharma drugs – instead of hydroxychloroquine.
Emergency Use Authority (screen grab)
Dr. Vladimir Zelenko, who authored a study on the efficacy of hydroxychloroquine, outlined the medical establishment’s campaign against the drug on the War Room: Pandemic show.
He emphasized that Dr. Fauci has “lied to the American people” by insisting that authorizing a treatment for COVID-19 rests on “controlled trials to get anything through the FDA.”
“That is not true. That has never been the historical precedent and almost no other medication has ever had to meet those standards,” Dr. Zelenko continued.
He also noted that due to the sheer existence of hydroxychloroquine – a potential treatment – “available drugs like Remdesevir and the vaccine by [the FDA’s] own internal rules cannot get EUA.”
Such a classification would “facilitate the availability and use” of the drug and represents a fast-track alternative to authorizing potential life-saving treatments during public health emergencies such as the ongoing pandemic.
THE DOCUMENT IN FULL: https://www.docdroid.net/Ispn8Ym/fink-fda-eua-licensing-slides-2020-pdf
[Blog Editor: In case some kind of crazy censorship renders the PDF link void, downloaded it.]
Or, as Dr. Zelenko describes, “there’ 150,000 dead corpses, most of which could have been avoided if Dr. Fauci did the moral and correct thing.”
The eight-page presentation entitled “Considerations for FDA Licensure vs. Emergency Use Authorization of COVID-19 Vaccines” posits two additional prerequisites for EUA: “declaration by HHS Secretary of emergency situation leading to serious or life-threatening disease or condition,” which occurred in January, and that the “known and potential benefits of the product outweigh the known and potential risks of the product.”
The National Pulse.
Edited by Raheem Kassam
The National Pulse SUPPORT PAGE
Actual science indicating HCQ not perfect but safe. All drugs have the potential for side effects. The Doctor/Patient has to weigh the drug for what is known of patient reactions on a personal basis. The science shows in MOST cases (long before COVID) HCQ designed for malaria has been helpful for other maladies for decades:
Lancet HCQ criticism refuted: https://www.webmd.com/lung/news/20200603/study-on-hydroxychloroquine-for-covid-questioned
Hydroxychloroquine is a Food & Drug Administration (FDA)-approved drug for the long-term treatment and prevention of autoimmune conditions like rheumatoid arthritis and systemic lupus. It’s a disease-modifying anti-rheumatic drug (DMARD) that decreases the swelling and pain caused by arthritis. It’s also prescribed for the treatment and prevention of acute attacks of malaria. Hydroxychloroquine is available in the US by prescriptions only. It’s sold both as a brand name and a generic version: https://www.rx2go.com/buy/hydroxychloroquine/
The progression of RA may be diminished in severity and duration by the combination of medicines and therapy that work best as determined by you and your physician. You can also put off joint damage, and in some cases, you can do more than just slow it down. Being able to stop joint damage can lessen pain and mean a better quality of life. Hydroxychloroquine is one of the medications that can be a valuable part of your treatment plan: https://www.rheumatoidarthritis.org/treatment/hydroxychloroquine/
Hydroxychloroquine and chloroquine are medications that have been used for a long time. Their most common use is for the treatment and prophylaxis of malaria. However, these antimalarial drugs are known to also have anti-inflammatory and antiviral effects and are used for several chronic diseases such as systemic lupus erythematosus with low adverse effects. The antiviral action of hydroxychloroquine and chloroquine has been a point of interest to different researchers due to its mechanism of action. Several in vitro studies have proven their effectiveness on severe acute respiratory syndrome virus and currently both in vitro and in vivo studies have been conducted on 2019 novel coronavirus (covid-19). The purpose of this article is to review the history and mechanism of actions of these drugs and the potential use they can have on the current covid-19 pandemic. …: https://pmj.bmj.com/content/early/2020/05/28/postgradmedj-2020-137785